Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

Blood (2019) 134 (Supplement_1): 4180.

https://doi.org/10.1182/blood-2019-125864

Published: 2019

Journal Articles

ASXL1 Mutations Detectable at Diagnosis May Predict Response to Imatinib in Patients with Chronic Myeloid Leukemia

Marcin M Machnicki, MSc, Monika Pepek, MSc, Iwona Solarska, PhD, Joanna Niesiobedzka-Krezel, MD PhD, Ilona Seferynska, MD PhD, Joanna Gora Tybor, MD PhD, Magdalena Zawada, PhD, Tomasz Sacha, MD PhD, Waldemar Sawicki, MD PhD, Ewa Wasilewska, MD PhD, Katarzyna Pruszczyk, MD, Malgorzata Rydzanicz, PhD, Rafal Ploski, MD PhD, Tomasz Skorski, MD PhD, Tomasz Stoklosa, MD PhD

Blood (2019) 134 (Supplement_1): 4148.

https://doi.org/10.1182/blood-2019-129834

Published: 2019

Journal Articles

The Role of Shelterin Complex and Post-Translational Non-Enzymatic Modification in Telomere Maintenance in Chronic Myeloid Leukemia

Anna Deregowska, MSc, Katarzyna Pruszczyk, MD, Iwona Solarska, PhD, Ilona Seferynska, MD PhD, Marek Dudzinski, MD, Maciej Wnuk, PhD, Tomasz Stoklosa, MD PhD

Blood (2018) 132 (Supplement 1): 5426.

https://doi.org/10.1182/blood-2018-99-112879

Published: 2018

Journal Articles

Somatic Mutations in Commonly Mutated Genes in Myeloid Malignancies May Preexist or Arise in the Course of Chronic Myeloid Leukemia - Different Scenarios of Progression Revealed By Targeted Next-Generation Sequencing

Marcin M Machnicki, Iwona Solarska, PhD, Rafal Ploski, MD PhD, Ilona Seferynska, MD PhD, Tomasz Stoklosa, MD PhD

Blood (2015) 126 (23): 2771.

https://doi.org/10.1182/blood.V126.23.2771.2771

Published: 2015

Journal Articles

Differential Expression of BIRC Family Genes In The Course Of Chronic Myeloid Leukemia – BIRC3 and BIRC8 As Potential New Candidates To Identify Disease Progression

Eliza Glodkowska-Mrowka, MD, Iwona Solarska, PhD, Piotr Mrowka, PhD, Katarzyna Bajorek, MSc, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Katarzyna Borg, PhD, Tomasz Stoklosa, MD, PhD

Blood (2013) 122 (21): 2718.

https://doi.org/10.1182/blood.V122.21.2718.2718

Published: 2013

Journal Articles

Purine Analogues Based Induction Regimen Followed By Allo-HSCT Is An Effective Treatment Modality Of Philadelphia Chromosome-Positive Acute Myeloid Leukemia-Retrospective Analysis Of Polish Adult Leukemia Group (PALG)

Agnieszka Wierzbowska, MD, PhD, Anna Szmigielska-Kaplon, MD, PhD, Agnieszka Pluta, MD, PhD, Ewa Wawrzyniak, PhD, Sebastian Grosicki, MD, Grzegorz Helbig, MD, PhD, Wanda Knopinska-Posluszny, MD, PhD, Tomasz Gromek, MD, PhD, Ilona Seferynska, MD, PhD, Ewa Lech-Maranda, Jerzy Holowiecki, Tadeusz Robak

Blood (2013) 122 (21): 1461.

https://doi.org/10.1182/blood.V122.21.1461.1461

Published: 2013

Journal Articles

Targeting Rac2 - Mitochondrial Respiratory Chain Complex III Signaling to Prevent Genomic Instability in Leukemia Stem and Progenitor Cells

Blood (2011) 118 (21): 2736.

https://doi.org/10.1182/blood.V118.21.2736.2736

Published: 2011

Journal Articles

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Eliza Glodkowska-Mrowka, MD, Piotr Mrowka, M.Sc., Magdalena Winiarska, PhD, Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Pawel Krzysztof Wlodarski, MD, PhD, Marek Jakobisiak, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2011) 118 (21): 2742.

https://doi.org/10.1182/blood.V118.21.2742.2742

Published: 2011

Journal Articles

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

Eliza Glodkowska-Mrowka, MD, Magda Winiarska, PhD, Piotr Mrowka, M.Sc., Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2010) 116 (21): 3400.

https://doi.org/10.1182/blood.V116.21.3400.3400

Published: 2010

Journal Articles

Mitochondrial Respiratory Chain Complex III Causes Genomic Instability In CML-CP.

Piotr Kopinski, Margaret Nieborowska-Skorska, MD, PhD, Grazyna Hoser, PhD, Danielle Ngaba, Regina Ray, Mateusz Koptyra, PhD, Elisabeth Bolton, Ilona Seferynska, MD, PhD, Tomasz Stoklosa, MD, PhD, Artur Slupianek, PhD, Mamatha R. Reddy, Martin Sattler, PhD, Tomasz Skorski, MD, PhD

Blood (2010) 116 (21): 1211.

https://doi.org/10.1182/blood.V116.21.1211.1211

Published: 2010

Journal Articles

BCR/ABL Requires Fanconi Anemia D2 (FANCD2) Protein to Transform Hematopoetic Stem Cells.

Tomasz Stoklosa, MD, PhD, Mateusz Koptyra, PhD, Grazyna Hoser, PhD, Ilona Seferynska, MD, PhD, Eliza Glodkowska, MD, Tomasz Skorski, MD, PhD

Blood (2009) 114 (22): 3249.

https://doi.org/10.1182/blood.V114.22.3249.3249

Published: 2009

Journal Articles

Monoubiquitination of the Fanconi Anemia D2 (FANCD2) Protein Regulates the Transforming Potential of BCR/ABL

Mateusz Koptyra, PhD, Tomasz Stoklosa, MD, PhD, Grazyna Hoser, PhD, Ilona Seferynska, MD, PhD, Eliza Glodkowska, MD, Tomasz Skorski, MD, PhD

Blood (2008) 112 (11): 3189.

https://doi.org/10.1182/blood.V112.11.3189.3189

Published: 2008

Journal Articles

BCR/ABL Kinase Inhibits Mismatch Repair To Reduce Apoptosis and Induce Point Mutations.

Tomasz Stoklosa, MD, PhD, Tomasz Poplawski, PhD, Grzegorz Basak, MD, PhD, Artur Slupianek, PhD, Janusz Blasiak, PhD, Ilona Seferynska, MD, PhD, Tomasz Skorski, MD, PhD

Blood (2007) 110 (11): 32.

https://doi.org/10.1182/blood.V110.11.32.32

Published: 2007

Journal Articles

Enhanced Phosphorylation of Nbs1, a Member of DNA Repair/Checkpoint Complex RAD50-Mre11-Nbs1, Can Be Targeted Simultaneously with BCR/ABL Kinase To Eliminate Leukemia Cells.

Lori Rink, PhD, Tomasz Stoklosa, MD, PhD, Margaret Nieborowska-Skorska, MD, PhD, Artur Slupianek, PhD, Ilona Seferynska, MD, Tomasz Skorski, MD, PhD

Blood (2006) 108 (11): 2127.

https://doi.org/10.1182/blood.V108.11.2127.2127

Published: 2006

Journal Articles

Bone Marrow Fibrosis in Chronic Idiopathic Myelofibrosis Is Associated with Megakaryocyte Expression of Osteoprotegerin.

Piotr Centkowski, MD, Joanna Sawczuk-Chabin, MD, Monika Prochorec-Sobieszek, MD, Joanna Dobrzanska, MD, Ilona Seferynska, MD, Iwona Solarska, MD, Miroslaw Majewski, MD, Krzysztof Warzocha

Blood (2005) 106 (11): 4955.

https://doi.org/10.1182/blood.V106.11.4955.4955

Published: 2005

Journal Articles

Complementary Diagnostic and Prognostic Value of Parallel Karyotyping and Molecular Diagnostics in Patients with Acute Leukemias.

Anna Ejduk, MD, Miroslaw Majewski, MD, Iwona Solarska, Hanna Makuch-Lasica, Iwona Kania, Grazyna Nowak, Ilona Seferynska, MD, PhD, Lech Konopka, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2005) 106 (11): 4527.

https://doi.org/10.1182/blood.V106.11.4527.4527

Published: 2005

Journal Articles

Randomized Comparison of Cladribine Containing Regimens and COP in Previously Untreated Patients with Small Lymphocytic, Marginal Zone and Follicular Lymphoma.

Ewa Kalinka, MD, Jaroslaw Wajs, MD, Kazimierz Sulek, Tadeusz Robak, Maria Blasinska-Morawiec, Joanna Sawczuk-Chabin, MD, Bernadetta Ceglarek, MD, Lech Konopka, Piotr Centkowski, MD, Ilona Seferynska, MD, Krzysztof Warzocha

Blood (2005) 106 (11): 4739.

https://doi.org/10.1182/blood.V106.11.4739.4739

Published: 2005

Journal Articles

Time-Sequenced G-CSF (Lenograstim) for the Treatment of Adult Acute Lymphoblastic Leukemia - Seven Year Follow-Up of the Polish Adult Leukemia Group 4–96 Study.

Sebastian Giebel, MD, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, MD, Slawomira Kyrcz-Krzemien, MD, Andrzej Hellmann, Anna Dmoszynska, Monika Paluszewska, MD, Tadeusz Robak, Lech Konopka, Ilona Seferynska, MD, Aleksander Skotnicki, Wojciech Baran, MD, Maria Adamczyk-Cioch, MD, Agata Wrzesien-Kus, MD, Krystyna Jagoda, PhD

Blood (2004) 104 (11): 2733.

https://doi.org/10.1182/blood.V104.11.2733.2733

Published: 2004

NARROW

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

ASXL1 Mutations Detectable at Diagnosis May Predict Response to Imatinib in Patients with Chronic Myeloid Leukemia

The Role of Shelterin Complex and Post-Translational Non-Enzymatic Modification in Telomere Maintenance in Chronic Myeloid Leukemia

Somatic Mutations in Commonly Mutated Genes in Myeloid Malignancies May Preexist or Arise in the Course of Chronic Myeloid Leukemia - Different Scenarios of Progression Revealed By Targeted Next-Generation Sequencing

Differential Expression of BIRC Family Genes In The Course Of Chronic Myeloid Leukemia – BIRC3 and BIRC8 As Potential New Candidates To Identify Disease Progression

Purine Analogues Based Induction Regimen Followed By Allo-HSCT Is An Effective Treatment Modality Of Philadelphia Chromosome-Positive Acute Myeloid Leukemia-Retrospective Analysis Of Polish Adult Leukemia Group (PALG)

Targeting Rac2 - Mitochondrial Respiratory Chain Complex III Signaling to Prevent Genomic Instability in Leukemia Stem and Progenitor Cells

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

Mitochondrial Respiratory Chain Complex III Causes Genomic Instability In CML-CP.

BCR/ABL Requires Fanconi Anemia D2 (FANCD2) Protein to Transform Hematopoetic Stem Cells.

Monoubiquitination of the Fanconi Anemia D2 (FANCD2) Protein Regulates the Transforming Potential of BCR/ABL

BCR/ABL Kinase Inhibits Mismatch Repair To Reduce Apoptosis and Induce Point Mutations.

Enhanced Phosphorylation of Nbs1, a Member of DNA Repair/Checkpoint Complex RAD50-Mre11-Nbs1, Can Be Targeted Simultaneously with BCR/ABL Kinase To Eliminate Leukemia Cells.

Bone Marrow Fibrosis in Chronic Idiopathic Myelofibrosis Is Associated with Megakaryocyte Expression of Osteoprotegerin.

Complementary Diagnostic and Prognostic Value of Parallel Karyotyping and Molecular Diagnostics in Patients with Acute Leukemias.

Randomized Comparison of Cladribine Containing Regimens and COP in Previously Untreated Patients with Small Lymphocytic, Marginal Zone and Follicular Lymphoma.

Time-Sequenced G-CSF (Lenograstim) for the Treatment of Adult Acute Lymphoblastic Leukemia - Seven Year Follow-Up of the Polish Adult Leukemia Group 4–96 Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only